The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Affiliations

¹ Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
² Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
³ Laboratory of Innate Immunity, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
⁴ Laboratory of Molecular Biology and Immunology, National Institute on Aging, Baltimore, MD, USA.
⁵ Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA.
⁶ Laboratory of Immunology, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. amy.rosenberg@fda.hhs.gov.

Maja Buszko et al. Nat Immunol. 2020 Oct.

. 2020 Oct;21(10):1146-1151.

doi: 10.1038/s41590-020-0779-1.

¹ Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
² Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
³ Laboratory of Innate Immunity, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
⁴ Laboratory of Molecular Biology and Immunology, National Institute on Aging, Baltimore, MD, USA.
⁵ Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA.
⁶ Laboratory of Immunology, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. amy.rosenberg@fda.hhs.gov.

No abstract available

References

1. Wrapp, D. et al. Science 367, 1260–1263 (2020). - DOI
1. Del Valle, D. M. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1051-9 (2020).
1. Diao, B. et al. Front. Immunol. 11, 827 (2020). - DOI
1. van de Veerdonk, F. L. et al. Elife https://doi.org/10.7554/eLife.57555 (2020).
1. Ni, L. et al. Immunity 52, 971–977.e3 (2020). - DOI